Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -2-
August 27, 2001
- Launching of Tarivid Generics Postponed Due to Patent Problems
August 27, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 27, 2001
- Nosan Corporation Ties Up with Midwest Research Institute
August 27, 2001
- Quality Reevaluation Enters Step 4 for 28 Ingredients
August 27, 2001
- MEDICAL DEVICE NEWS IN BRIEF
August 27, 2001
- Kirin Forms Research Alliance with Hyseq
August 27, 2001
- Use of Orange Book, Rx in Generic Name Recommended for Promotion of Generics: EAD Director
August 27, 2001
- Fujirebio, diaDexus Tie Up to Develop Cancer Diagnostic Agents
August 27, 2001
- Takeda, Pharmacia to Launch Smoking Cessation Aid Nicorette in September
August 20, 2001
- Tiracoxib Designated as Orphan for Familial Adenomatous Polyposis
August 20, 2001
- Asahi Kasei Licenses Out Fasudil to Schering AG
August 20, 2001
- Genomic Drug Discovery, Tailor-Made Medicine to Receive Top Priority in FY2002 Budgeting
August 20, 2001
- Takeda, Bayer to Discuss with Korosho on Cerivastatin
August 20, 2001
- Generics of 20 Drugs to Be Tested: 14th Quality Reevaluation
August 20, 2001
- Daiichi to Clear Goals for 1st Half of FY2001: President Morita
August 20, 2001
- 29 Mono-drugs, 1 Combination Designated: 15th Quality Reevaluation
August 20, 2001
- FPMAJ Presents Opinions on Proposed Drug Classification System
August 20, 2001
- Mean Life Expectancy Increases to 77.64 years for Men, 84.62 years for Women
August 20, 2001
- WORLD NEWS IN BRIEF
August 20, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…